64 related articles for article (PubMed ID: 31135274)
1. Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway.
Guo H; Wang Z; Yin K; Ma R; Zhang Y; Yin F; Li H; Yin D
Mol Carcinog; 2024 Apr; 63(4):701-713. PubMed ID: 38411346
[TBL] [Abstract][Full Text] [Related]
2. Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the COX-2/PGE2/JAK2/STAT3/MMP pathway.
Wang Q; Zhang R; He Y; Mao G; Kong Z
Int J Radiat Biol; 2024; 100(5):791-801. PubMed ID: 38442139
[TBL] [Abstract][Full Text] [Related]
3. RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the JAK1-STAT3-CD24/MMPs axis.
Zhang FX; Xu P; Zhang LJ; Fan R; Zhang HX; Liu DH; Liu K; Shen DY
Int Immunopharmacol; 2023 Dec; 125(Pt A):111129. PubMed ID: 37897947
[TBL] [Abstract][Full Text] [Related]
4. Linc00511 Promotes Thyroid Cancer Through the miR-4739/RNF38 Pathway.
Liu Y; He L; Shi J; Jiang X; Zhang J; Feng Y; Liu W
Altern Ther Health Med; 2024 May; ():. PubMed ID: 38702149
[TBL] [Abstract][Full Text] [Related]
5.
Zhang C; Yang L; Zhang H; Wu F; Zhang Y; Zhang K; Wu C; Li R; Dong M; Zhao S; Song H
Am J Physiol Endocrinol Metab; 2024 Jun; 326(6):E832-E841. PubMed ID: 38656129
[TBL] [Abstract][Full Text] [Related]
6. Retracted: IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway.
International BR
Biomed Res Int; 2024; 2024():9796319. PubMed ID: 38229987
[TBL] [Abstract][Full Text] [Related]
7. A review on the role of LINC00511 in cancer.
Ghafouri-Fard S; Safarzadeh A; Hussen BM; Taheri M; Ayatollahi SA
Front Genet; 2023; 14():1116445. PubMed ID: 37124625
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of LINC00511 enhances radiosensitivity of lung adenocarcinoma via regulating miR-497-5p/SMAD3.
Li C; Fu Y; He Y; Huang N; Yue J; Miao Y; Lv J; Xiao Y; Deng R; Zhang C; Huang M
Cancer Biol Ther; 2023 Dec; 24(1):2165896. PubMed ID: 36861928
[TBL] [Abstract][Full Text] [Related]
9. Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology.
Kozłowska-Masłoń J; Guglas K; Paszkowska A; Kolenda T; Podralska M; Teresiak A; Bliźniak R; Lamperska K
J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294743
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00511 promotes proliferation, invasion, and migration of non-small cell lung cancer cells by targeting miR-625-5p/GSPT1.
Cheng Y; Wang S; Mu X
Transl Cancer Res; 2021 Dec; 10(12):5159-5173. PubMed ID: 35116366
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Landscapes of Long Noncoding RNA in Thyroid Carcinoma: Biological Functions and Clinical Significance.
Zhu J; Liu C; Wang D; Cao X; Wang S; Liu Y; Wang J; Li P; He Q
Front Oncol; 2021; 11():706011. PubMed ID: 34447696
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LINC00511 Acts as an Oncogene in Colorectal Cancer via Sponging miR-29c-3p to Upregulate NFIA.
Hu Y; Zhang Y; Ding M; Xu R
Onco Targets Ther; 2020; 13():13413-13424. PubMed ID: 33536761
[TBL] [Abstract][Full Text] [Related]
13. Long Intergenic Non-protein Coding RNA 511 in Cancers.
Wang XF; Liang B; Chen C; Zeng DX; Zhao YX; Su N; Ning WW; Yang W; Huang JA; Gu N; Zhu YH
Front Genet; 2020; 11():667. PubMed ID: 32733536
[No Abstract] [Full Text] [Related]
14. The role of long intergenic noncoding RNA 00511 in malignant tumors: a meta-analysis, database validation and review.
Ding J; Cao J; Chen Z; He Z
Bioengineered; 2020 Dec; 11(1):812-823. PubMed ID: 32713253
[TBL] [Abstract][Full Text] [Related]
15. LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis.
Agbana YL; Abi ME; Ni Y; Xiong G; Chen J; Yun F; Yi Z; Zhang Q; Yang Z; Kuang Y; Zhu Y
BMC Cancer; 2020 Jul; 20(1):682. PubMed ID: 32698787
[TBL] [Abstract][Full Text] [Related]
16. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of LINC00511 promotes radiosensitivity of thyroid carcinoma cells via suppressing JAK2/STAT3 signaling pathway.
Chen Y; Bao C; Zhang X; Lin X; Fu Y
Cancer Biol Ther; 2019; 20(9):1249-1257. PubMed ID: 31135274
[TBL] [Abstract][Full Text] [Related]
18. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
[TBL] [Abstract][Full Text] [Related]
19. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.
Park SY; Lee CJ; Choi JH; Kim JH; Kim JW; Kim JY; Nam JS
J Exp Clin Cancer Res; 2019 Sep; 38(1):399. PubMed ID: 31511084
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
